Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Total Revenue

Amneal Pharmaceuticals Inc Total Revenue Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Total Revenue from 2016 to 2018. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the last 12 months ending December 12, 2018 was $1,663m a 34.87% increase of 580m year over year
  • Amneal Pharmaceuticals Inc Annual Total Revenue for 2018 was $1,663m a 37.84% increase of 629m from 2017
  • Amneal Pharmaceuticals Inc Annual Total Revenue for 2017 was $1,034m a 1.49% increase of 15m from 2016
  • Amneal Pharmaceuticals Inc Annual Total Revenue for 2016 was $1,018m a 14.92% increase of 152m from 2015
Other Income Statement Metrics:
  • Amneal Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $109m a 21.60% increase of 24m year over year
  • Amneal Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-9m a 687.76% decrease of -60m year over year
View Chart On Koyfin

Quarterly AMRX Total Revenue Data

12/2018$498m
09/2018$476m
06/2018$414m
03/2018$275m
12/2017$293m
09/2017$255m
06/2017$260m
03/2017$226m
12/2016$299m

Annual AMRX Total Revenue Data

2018$1,663m
2017$1,034m
2016$1,018m
2015$866m
2014$786m